Who owns Karyopharm Therapeutics Inc note 3.000%10/1?
- CUSIP Number: 48576uaa4
Tip: Access positions for across all investors
Analyze quarterly positions in Karyopharm Therapeutics Inc note 3.000%10/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Karyopharm Therapeutics Inc note 3.000%10/1 stock
Who bought or sold Karyopharm Therapeutics Inc note 3.000%10/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Affinity Asset Advisors | 12M | $9.6M | 26% | Sep 2024 |
|
| Opaleye Management | 6.0M | $4.0M | 0% | Sep 2024 |
|
| Capstone Investment Advisors | 3.0M | $2.4M | -45% | Sep 2024 |
|
| Exome Asset Management | 2.0M | $1.5M | 100% | Sep 2024 |
|
| BLB^B Advisors | 75k | $59k | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 38k | $25k | 0% | Sep 2024 |
|
Who sold out of Karyopharm Therapeutics Inc note 3.000%10/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Davidson Kempner Capital Management | Mar 2024 | 29M | $15M |
| DeepCurrents Investment Group | Mar 2024 | 5.3M | $4.7M |
| Verition Fund Management | Mar 2024 | 1.7M | $897k |